🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of MP-513 ...
Status
Completed
Location
Multiple Locations
Start Date
2009-12
Trial ID
NCT01026194
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01230749
Treatments Being Tested
Prostate cancer is the most common cancer in men in the United States. Supp...
Status
Withdrawn
Location
Saint Louis University
Start Date
2020-12-02
Trial ID
NCT04658849
Treatments Being Tested
The purpose of this study is to determine the safety and efficacy of an inv...
Status
Completed
Location
Multiple Locations
Start Date
2004-06-30
Trial ID
NCT00086515
Treatments Being Tested
The purpose of this pilot study is to compare two strategies intended to im...
Status
Completed
Location
Sticht Center on Aging, Wake Forest University Baptist Medical Center
Start Date
2006-04
Trial ID
NCT00315146
Treatments Being Tested
This study will test the effect of four common oral anti-diabetic agents on...
Status
Unknown
Location
Oslo University Hospital, Aker Hospital
Start Date
2021-02-10
Trial ID
NCT04662866
To define the relative efficacy, safety and tolerability profiles of oral d...
Status
Terminated
Location
Providence Clinical Research
Start Date
2008-12
Trial ID
NCT00814372
The insulin sensitizing effects of metformin and pioglitazone in the skelet...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-09-01
Trial ID
NCT03452267
Treatments Being Tested
The purpose of this study is to compare the efficacy of Alogliptin, once da...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00655863
Treatments Being Tested
Primary objective: Efficacy of pioglitazone (45 mg/day) as add-on therapy ...
Status
Terminated
Location
Department of Neurology, University of Ulm
Start Date
2008-05
Trial ID
NCT00690118
Treatments Being Tested